tm logo

Monitor this mark

View On USPTO

ZEPZUMA SUMATRIPTAN
Dead/Cancelled
CANCELLED – SECTION 71

on 31 May 2024

Last Applicant/ Owned by

CROSSJECT

60 L Avenue du 14 juillet

CHENOVE

FR

F21300

Serial Number

79204399 filed on 30th Nov 2016

Registration Number

5332151 registered on 14th Nov 2017

in the Principal Register

Correspondent Address

Brooks R. Bruneau

Brooks R. Bruneau FisherBroyles, LLP

Second Floor

Princeton, NJ 08540

UNITED STATES

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

ZEPZUMA SUMATRIPTAN

Pharmaceutical products, namely, pharmaceutical preparations based on Sumatriptan for the treatment of migraines and cluster headaches

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical products, namely, pharmaceutical preparations based on Sumatriptan for the treatment of migraines and cluster headaches

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 79204399

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 04774.T665US

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Design Code(s)

01.01.02 -

A single star with four points

26.01.21 -

Circles that are totally or partially shaded

Legal History

Show more

Status DateAction Taken
31st May 2024CANCELLED SECTION 71
14th Nov 2022COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
13th Apr 2018FINAL DECISION TRANSACTION PROCESSED BY IB
21st Feb 2018FINAL DISPOSITION PROCESSED
21st Feb 2018FINAL DISPOSITION NOTICE SENT TO IB
14th Feb 2018FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
14th Nov 2017REGISTERED-PRINCIPAL REGISTER
29th Aug 2017PUBLISHED FOR OPPOSITION
29th Aug 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09th Aug 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED